QCELLUS LASER

FDA Premarket Approval P050026 S001

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for: 1) change in the name of the device from activis laser to qcellus laser; 2) change in the laser design to combine the laser module and slit lamp adapter into a single unit to be mounted directly on the tonometer post of a haag-streit 900 bm/bq slit lamp or equivalent; and 3) change manufacturing site for the qcellus laser to qlt, inc. , vancouver, bc, canada.

DeviceQCELLUS LASER
Generic NameSystem, Laser, Photodynamic Therapy
ApplicantBausch Health Ireland Limited
Date Received2012-11-19
Decision Date2013-09-26
PMAP050026
SupplementS001
Product CodeMVF 
Advisory CommitteeGeneral & Plastic Surgery
Supplement TypeNormal 180 Day Track
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product Yes
Applicant Address Bausch Health Ireland Limited 208 Val Des Bons Malades grand Duchy Of Luxembourg L-212-2121

Supplemental Filings

Supplement NumberDateSupplement Type
P050026Original Filing
S002 2020-09-04 Normal 180 Day Track
S001 2012-11-19 Normal 180 Day Track

NIH GUDID Devices

Device IDPMASupp
06429810677020 P050026 002

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.